PATENT CLAIM ANALYSIS

Application Number: 16140120
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "654000"]

Abstract:
A method of treating symptoms of a subtype of epilepsy, e.g., Dravet syndrome, in a patient diagnosed with a subtype of epilepsy, by administering to the patient an effective dose of a fenfluramine formulation in combination with a ketogenic diet over a period of time sufficient to reduce or completely eliminate seizures in the patient. Also provided are compositions and kits finding use in practicing embodiments of the methods.

Claim (Index 2):
The method of  claim 1 , wherein the patient has been diagnosed with Dravet Syndrome.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.53061
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16090039', '14881969', '14447253', '15771379', '15449402']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7164461048766694
- 35 USC 102 Novelty (BERT): 0.5038726513022649
- Combined Prediction Score: 0.695188759519229
- Mean Citation Score: 270.84679
- Max Citation Score: 286.414
- Similarity Product: 248.23468760943408

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test